New Study Quantifies Pain by Assigning a Monetary Value to Enhance Measurement Accuracy

A pioneering international study introduces a monetary approach to pain measurement, offering more accurate and comparable assessments for clinical and research purposes.
A groundbreaking study published in the journal Social Science & Medicine introduces a novel approach to measuring pain by assigning a monetary value to the discomfort experienced. Conducted by an international team led by Lancaster University, the research aims to improve the precision of pain assessment methods used in clinical and research settings.
Traditionally, pain levels are recorded using a simple numerical scale from 1 to 10, but this method has notable limitations. Different individuals interpret the scale differently, making cross-person comparisons difficult and often unreliable. To address this, the study explores an alternative measure: asking participants how much money they would accept to endure a particular painful stimulus again.
Involving over 300 volunteers aged 18 to 60, the experiments involved exposing participants to mild pain and collecting data through two methods—self-rated pain intensity on a scale and a monetary compensation amount they would require to repeat the experience. The study also included an analgesia trial, where one group received a placebo and another received pain relief cream.
The findings indicate that the monetary measure offers several advantages:
- Better differentiation between various pain levels
- More consistent detection of pain relief effects
- Facilitates meaningful individual comparisons
Professor Carlos Alós-Ferrer from Lancaster University Management School explained that converting pain into a monetary value creates a shared and interpretable scale. While individuals may assign different prices to the same pain, the question itself provides a clearer, standardized reference point that improves measurement precision.
This approach holds significant promise for clinical trials, as it allows for more accurate assessments of pain management strategies. Accurate pain measurement is crucial because inadequate assessment can lead to poor treatment, affecting patient quality of life and straining healthcare systems. For example, over $600 billion annually is spent in the U.S. on pain treatment—a figure that surpasses expenditures for heart disease and diabetes.
The study’s authors suggest that this monetary valuation method could complement existing pain scales and foster advancements in pain research and management. Refinement of pain assessment techniques is vital for improving patient outcomes and optimizing healthcare strategies.
For more details, visit the full article at Science Direct.
Source: medicalxpress.com
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Reevaluating the Role of Anticoagulation in Patients with Device-Detected Atrial Fibrillation
New findings from the NOAH—AFNET 6 trial suggest that anticoagulation offers minimal benefit and increased risks for patients with device-detected atrial fibrillation, emphasizing personalized treatment strategies.
2025 Blood Pressure Guidelines Focus on Prevention and Early Intervention to Combat Heart Disease and Stroke
The 2025 high blood pressure guidelines highlight the importance of early detection, lifestyle changes, and personalized treatment to reduce cardiovascular risks and prevent cognitive decline. Incorporating new risk assessments and expanded testing, these guidelines provide updated strategies for clinicians and patients alike.
Detection of Highly Potent Synthetic Opioids in Used Syringes Raises Overdose Concerns
Researchers in South Australia have detected highly potent synthetic opioids, nitazenes, in discarded syringes, raising serious concerns about overdose risks and the illegal drug market's evolving dangers.



